News 2014-09-12
2014 Semi-Annual & OD project summary conference
The conference of 2014 semi-annual and OD project summary was held on Aug. 31st to Sep. 2nd 2014 at Jin Fo Shan in Nanshuan District.
During the meeting, we summarized the progress of “Three Battles (BPM, GMP and KAM)”which were confirmed at the beginning of this year. We also concluded and analyzed the performance of each economic indicator in H1 of 2014.
The redefined core values and its connotations were officially published on Sep. 1st, 2014, and thus determined the concept of Porton culture on its mission, vision and core values.
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes
News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.
